[2-Bromo-4-(methylsulfonyl)phenyl]hydrazine, 95.0%, 250mg

N-methyl-2-(o-tolyl)acetamide, 98%, 5g

2-Methoxy-4-nitroaniline>99.0%(GC)25g

ethyl 4-(2,5-dimethyl-1H-pyrrol-1-yl)benzenecarboxylate, 95%, 95.0%, 50g

5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

1-(4-(Hydroxymethyl)phenyl)ethanone, 95.0%, 25g

1,2-Phenylenediamine, 99.0%, 100g

6-(1H-imidazol-1-yl)pyrimidin-4-amine, 98%, 1g

o-Xylol, min. 98 %, zur Synthese, 500 ml, Glasverpackung

Rotilabo®-Reaktionsgefäße, 1,5 ml, farblos, unsteril, 500 Stück

3-Bromo-4-methoxy-5-nitro-benzoic acid methyl ester, 98.0%, 25g

1-(3-Bromopyridin-2-yl)ethanone, 95.0%, 1g

(S)-(-)-Terpineol, 97.0%, 1kg